- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma) in Hong Kong
Total 546 results
-
National OncoVentureHanmi Pharmaceutical Company LimitedTerminatedAdenocarcinoma of Lung Stage IV | Adenocarcinoma of Lung Stage IIIBKorea, Republic of
-
AstraZenecaCompletedNon-Small Cell Lung CancerItaly, Spain, France, Korea, Republic of, Hungary, Japan, China, Taiwan, Hong Kong, Germany, Russian Federation
-
Bristol-Myers SquibbRecruitingCarcinoma, HepatocellularUnited States, Taiwan, Spain, France, Korea, Republic of, Germany, Puerto Rico, China, Japan, Canada, Hong Kong, Australia, Poland, Singapore, Italy
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
ImunonCompletedHepatocellular CarcinomaUnited States, Taiwan, Korea, Republic of, China, Italy, Hong Kong, Thailand, Canada, Malaysia, Japan, Philippines
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingAdvanced Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States, Canada, Australia, Hong Kong, Korea, Republic of
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
National Cancer Institute (NCI)Active, not recruitingLung Non-Squamous Non-Small Cell Carcinoma | Stage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7United States, Puerto Rico
-
BayerCompletedCarcinoma, Renal CellUnited States, Canada
-
GOG FoundationNational Cancer Institute (NCI)Active, not recruitingOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma and other conditionsUnited States
-
Shanghai Henlius BiotechRecruitingLimited-Stage Small Cell Lung CancerUnited States, China, Greece, Spain, Austria, Czechia, Germany, Hungary, Latvia, Netherlands, Poland
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedNeuroendocrine Carcinoma of the SkinUnited States
-
PfizerCompletedNon-small Cell Lung Cancer With EGFR-Activating MutationsItaly, Poland, China, Hong Kong, Spain, Korea, Republic of, Japan
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Endometrial Carcinoma | Pancreatic CarcinomaUnited States, Germany, Italy, Japan, Belgium, Switzerland, Korea, Republic of, Hong Kong, Finland, France, Spain
-
AmgenRecruitingSmall Cell Lung CarcinomaUnited States, Spain, Austria, Switzerland, United Kingdom, France, Australia, Germany, Japan, Taiwan, Poland, Hong Kong, Netherlands
-
BayerCompletedCarcinoma, HepatocellularBelgium, France, Switzerland, Germany, United States, Austria, New Zealand, Hungary, Korea, Republic of, Italy, Hong Kong, Thailand, Spain, Taiwan, Japan, Czechia, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States, France, Italy, Korea, Republic of, Peru, Spain, United Kingdom, Philippines, China, Germany, Hong Kong, Argentina, Austria, Canada, Israel, Taiwan, Mexico, Thailand, Belgium, Australia, Singapore, Netherlands
-
PfizerCompletedNon Squamous Lung CancerUnited States, Switzerland, Taiwan, Spain, Korea, Republic of, Canada, United Kingdom, Singapore, Japan, Germany, Luxembourg, Australia, France, Brazil, Italy, Hong Kong, China, Belgium, Russian Federation, Austria, Finland, Portugal and more
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaItaly, United States, Spain, China, Korea, Republic of, Taiwan, France, Japan, Germany, Belgium, Austria, Brazil, Czechia, Canada, Poland, United Kingdom, Israel, Australia, Hong Kong, Switzerland
-
AmgenRecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States, Israel, Italy, Spain, Switzerland, Canada, Australia, Germany, United Kingdom, Austria, France, Japan, Taiwan, China, Belgium, Poland, Thailand, Czechia, Singapore, Hungary, Argentina, Brazil, Romania, Portuga... and more
-
Hoffmann-La RocheCompletedColorectal CancerCanada, United States, Italy, Korea, Republic of, United Kingdom, Belgium, Russian Federation, Hong Kong, Spain, Australia, Poland
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Aventis PharmaceuticalsTerminatedLung CancerUnited States
-
Boehringer IngelheimCompletedAdenocarcinoma | Carcinoma, Non-Small-Cell LungHong Kong, Canada, Korea, Republic of, Belgium, Australia, United States, Taiwan, United Kingdom, Germany, Italy, Japan, Austria, Thailand, Peru, Ireland, Russian Federation, Philippines, France, Brazil, Chile, Argentina, Hungary, M... and more
-
Bristol-Myers SquibbCompletedHepatocellular CarcinomaUnited States, Argentina, Australia, Canada, China, France, Hong Kong, Italy, Japan, Korea, Republic of, Taiwan, Thailand, Spain
-
NRG OncologyNational Cancer Institute (NCI)RecruitingMetastatic Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Unresectable Renal Cell CarcinomaUnited States
-
PfizerTerminatedCarcinoma, HepatocellularUnited States, Belgium, Spain, Canada, Italy, Korea, Republic of, Poland, Turkey, Germany, Singapore, Taiwan, China, France, Hong Kong, South Africa, Australia, Japan, Sweden, Malaysia, Philippines, Thailand, Russian Federation, United...
-
AstraZenecaCompletedCarcinoma, Non- Small Cell LungUnited States, Canada, France, Italy, Netherlands, Spain, Belgium, Poland, Taiwan, Vietnam, Korea, Republic of, Brazil, Czechia, Hungary, Japan, Peru, Russian Federation, Hong Kong, Israel, Greece, Australia, Singapore, Turkey, India, A...
-
AVEO Pharmaceuticals, Inc.Biodesix, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, Australia, Taiwan, Singapore, Hong Kong, Italy
-
ExelixisCompletedHepatocellular CarcinomaBelgium, Hong Kong, Korea, Republic of, Canada, France, Taiwan, United States, Germany, Spain, United Kingdom, Singapore, Australia, Italy, Netherlands, Poland, Turkey, Ireland, New Zealand, Romania
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian Tube Clear Cell Adenocarcinoma and other conditionsUnited States
-
Hoffmann-La RocheCompletedAnemiaBelgium, Italy, Poland, Spain, Hong Kong, Canada, France, Greece, Czech Republic, Austria, Estonia, Hungary, Australia, Germany, Finland
-
Aristotle University Of ThessalonikiNot yet recruitingMedullary Thyroid CancerChina, Switzerland, Spain, Greece, United States, Austria, Belgium, Brazil, Bulgaria, Colombia, Croatia, France, India, Iraq, Italy, Jordan, Morocco, Poland, Serbia, Slovakia, Thailand, Turkey, Ukraine, Vietnam
-
BayerCompletedCarcinoma, HepatocellularBelgium, China, Hong Kong, Switzerland, Japan, France, Spain, Germany, United States, Austria, Czechia, United Kingdom, Korea, Republic of, Thailand, New Zealand, Hungary, Israel, Italy, Taiwan, Singapore, Turkey
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedGastric Cancer | Esophageal Cancer | Adenocarcinoma of the Gastroesophageal JunctionUnited States
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Canada, Austria, Finland, France, Greece, Korea, Republic of, Panama, Portugal, Spain, Turkey, United Kingdom, Taiwan, Brazil, Germany, Poland, Chile, Guatemala, Russian Federation, Switzerland, Thailand, Ukraine, Serb... and more
-
AstraZenecaActive, not recruitingHepatocellular CarcinomaUnited States, Canada, Brazil, France, Italy, Russian Federation, Spain, Vietnam, Korea, Republic of, China, Germany, Ukraine, Japan, Hong Kong, Taiwan, India, Thailand
-
PfizerCompletedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Brazil, Spain, United Kingdom, Singapore, Canada, Hong Kong, Poland, Puerto Rico
-
Merck KGaA, Darmstadt, GermanyCompletedNon Small Cell Lung Cancer (NSCLC)Sweden, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Turkey, United Kingdom, Germany, Poland, Ukraine, Argentina, Austria, Hungary, Netherlands, Slovakia, Taiwan, Chil... and more
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerAustralia, Belgium, France, Italy, Hong Kong, Canada, Denmark, Taiwan, Russian Federation, United Kingdom, Spain, Hungary, Czech Republic, Poland, Germany, Netherlands
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerAustralia, France, Germany, Spain, China, Hong Kong, Canada, Sweden, Colombia, Taiwan, United Kingdom, Russian Federation, Finland, Austria, Estonia, Hungary, Netherlands, Latvia, Italy, Mexico, Slovenia, Turkey, Bosnia and Herzegovina and more
-
NovoCure Ltd.Active, not recruitingPancreas AdenocarcinomaUnited States, China, Belgium, Czechia, Korea, Republic of, Spain, Hong Kong, France, Australia, Italy, Hungary, Germany, Croatia, Canada, Mexico, Israel, Austria, Switzerland, Brazil, Poland
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHepatocellular CarcinomaUnited States, Australia, Austria, Belgium, Canada, China, Czechia, France, Germany, Hong Kong, Israel, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
AstraZenecaCompletedNon-Small Cell Lung CancerPhilippines, China, Malaysia, Japan, Hong Kong, Taiwan, Thailand, Indonesia, Singapore
-
PfizerCompletedKidney NeoplasmsUnited States, China, Malaysia, India, Taiwan, Russian Federation, Mexico, Bosnia and Herzegovina, South Africa, Bulgaria, Chile, Philippines, Romania, Ukraine
-
Eisai LimitedMerck Sharp & Dohme LLCCompletedHepatocellular Carcinoma (HCC)Italy, Korea, Republic of, Poland, United States, Australia, Belgium, Canada, China, France, Germany, Hong Kong, Israel, Japan, Malaysia, Philippines, Russian Federation, Singapore, Spain, Taiwan, Thailand, United Kingdom
-
Hoffmann-La RocheRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, China, Japan, Australia, Taiwan, Brazil, Argentina, Hong Kong
-
Novartis PharmaceuticalsCompletedCarcinomaChina, Italy, Taiwan, Germany, Hungary, Belgium, Spain, Australia, Austria, France, Hong Kong, Thailand, Korea, Republic of, Canada, Japan, Israel, United States, Greece
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)Israel, Taiwan, United States, Australia, Hong Kong, Chile, Korea, Republic of, Canada, Malaysia
-
Genentech, Inc.Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerPoland, Belgium, Spain, United States, Canada, South Africa, Russian Federation, Hong Kong, Taiwan, Japan, France, United Kingdom, Australia, Germany, Hungary, Korea, Republic of, Netherlands, Croatia, Serbia, Israel, Ukraine, Peru, Brazi... and more